..And I gave you the opportunity to adjust that offer to a deep pocketed financier or a big pharma and you refused!; ). My premise has been that big pharma will only acknowledge their weaker position with checkpoint inhibitors when they absolutely must make a deal. In the mean time they take in billions every quarter without having to defer to the better product which will at some point over the next 15 months or so likely be classified tissue agnostic and be produced utilizing Flaskworks. Best wishes.
Market Data 
Markets 
AI
